Ivey Named as Francke Medal Award Winner by ASHP
The James L. Winkle College of Pharmacy congratulates professor emerita Marianne Ivey, PharmD, MPH, FASHP, for being named by the American Society of Health-System Pharmacists (ASHP) as the 2017 recipient of the Donald E. Francke Medal (52nd Midyear Clinical Meeting, December 2017). The medal honors pharmacists who have made significant international contributions to advance pharmacy practice.
ASHPs more than 43,000 members include pharmacists, student pharmacists, and pharmacy technicians. For 75 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety.
The announcement states: "Dr. Ivey has made sustained contributions to international pharmacy education, practice, and research, both as a mentor to foreign pharmacy students and as a leader in the Hospital Section of the International Pharmaceutical Federation.
Ivey joined the James L. Winkle College of Pharmacy in 1988 and retired in April 2016. She has many years of hospital pharmacy executive leadership roles and was in charge of post-doctoral residency programs.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.